Filing Flows › Lyell Immunopharma (LYEL) › Recalls, complaints & regulation
Lyell Immunopharma (LYEL): clinical trials
Lyell Immunopharma (LYEL) beyond its filings: 3 active clinical trials.
Lyell Immunopharma's latest quarter
Lyell Immunopharma, Q3 2026: revenue $3K (-80% year over year), net loss $45.5M, operating cash flow −$34.6M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does Lyell Immunopharma have?
3 active studies on ClinicalTrials.gov, 1 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.